Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.850 |
None |
1.000 |
8 |
2
|
2008 |
2018 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.050 |
None |
1.000 |
5 |
|
2011 |
2020 |
Inflammatory Bowel Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1577
|
605
|
0.340 |
None |
0.800 |
5 |
2
|
2009 |
2017 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
5 |
4
|
2015 |
2019 |
West Syndrome
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
149
|
28
|
0.340 |
None |
1.000 |
5 |
|
2008 |
2017 |
Infantile Spasm
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
93
|
39
|
0.040 |
None |
1.000 |
4 |
|
2008 |
2015 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1458
|
827
|
0.030 |
None |
1.000 |
3 |
3
|
2008 |
2011 |
Celiac Disease
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
527
|
263
|
0.320 |
None |
1.000 |
3 |
|
2008 |
2011 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2018 |
Steroid-resistant nephrotic syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
73
|
25
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.020 |
None |
0.500 |
2 |
|
2014 |
2015 |
High-Grade Prostatic Intraepithelial Neoplasia
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
111
|
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Crohn Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1382
|
1147
|
0.020 |
None |
1.000 |
2 |
1
|
2009 |
2011 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |
Steroid resistant nephrotic syndrome of childhood
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
73
|
19
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Memory Disorder, Semantic
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
43
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Adverse effects, not elsewhere classified
|
disease |
|
Injury or Poisoning
|
55
|
54
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Neurobehavioral Manifestations
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
77
|
3
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |